Jafron Biomedical Co. Ltd. (300529)
SZSE
Closed
Sep 11, 2026
Day's Range
14.9052 wk Range
14.73Overview - 300529 - Jafron Biomedical Co. Ltd.
Key Statistics
Valuation
Enterprise Value
11.25B
P/E (Trailing)
‪23.91‬
P/E (Forward)
‪9.53‬
PEG Ratio
‪9.53‬
Price / Sales (TTM)
‪6.69‬
Price / Book
‪3.58‬
EV / EBITDA
‪14.19‬
Profitability
Gross Margin
‪79.88%‬
Profit Margin
‪27.49%‬
Operating Margin
‪36.80%‬
Return on Assets
‪8.09%‬
Return on Equity
‪15.98%‬
Ownership
Shares Outstanding
798.60M
Float
374.60M
Held by Insiders
‪50.39%‬
Held by Institutions
‪6.73%‬
Price stats
Beta
‪0.33‬
50-Day Avg
‪16.63‬
200-Day Avg
‪18.57‬
Dividends
Payout Ratio
‪77.61%‬
Frequency
Annual
Analyst Consensus
2 analysts
Average price target
‪CN¥ 24.11‬Market Cap - 300529 - Jafron Biomedical Co. Ltd.
Peers - 300529 - Jafron Biomedical Co. Ltd.
Peer Comparison
Compared with companies in Medical Devices listed on SZSE.
Profile Summary - 300529 - Jafron Biomedical Co. Ltd.
About
Jafron Biomedical Co. Ltd. is a notable entity in the field of biotechnology, primarily focused on the research, development, and production of advanced medical devices, particularly in the area of blood purification. Founded in China, the company specializes in producing blood purifiers used in clinical treatments…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
